Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation

被引:60
作者
Kim, SJ [1 ]
Kim, JH [1 ]
Kim, YG [1 ]
Lim, HS [1 ]
Oh, JW [1 ]
机构
[1] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea
关键词
D O I
10.1074/jbc.M408617200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The hepatitis C virus (HCV) NS5B protein is the viral RNA-dependent RNA polymerase required for replication of the HCV RNA genome. We have identified a peptide that most closely resembles a short region of the protein kinase C-related kinase 2 (PRK2) by screening of a random 12-mer peptide library displayed on the surface of the M13 bacteriophage with NS5B proteins immobilized on microwell plates. Competitive phage enzyme-linked immunosorbent assay with a synthetic peptide showed that the phage clone displaying this peptide could bind HCV RNA polymerase with a high affinity. Coimmunoprecipitation and colocalization studies demonstrated in vivo interaction of NS5B with PRK2. In vitro kinase assays demonstrated that PRK2 specifically phosphorylates NS5B by interaction with the N-terminal finger domain of NS5B ( amino acids 1 - 187). Consistent with the in vitro NS5B-phosphorylating activity of PRK2, we detected the phosphorylated form of NS5B by metabolic cell labeling. Furthermore, HCV NS5B immunoprecipitated from HCV subgenomic replicon cells was specifically recognized by an antiphosphoserine antibody. Knock-down of the endogenous PRK2 expression using a PRK2-specific small interfering RNA inhibited HCV RNA replication. In contrast, PRK2 overexpression, which was accompanied by an increase of in the level of its active form, dramatically enhanced HCV RNA replication. Altogether, our results indicate that HCV RNA replication is regulated by NS5B phosphorylation by PRK2.
引用
收藏
页码:50031 / 50041
页数:11
相关论文
共 74 条
[1]
Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus [J].
Ago, H ;
Adachi, T ;
Yoshida, A ;
Yamamoto, M ;
Habuka, N ;
Yatsunami, K ;
Miyano, M .
STRUCTURE, 1999, 7 (11) :1417-1426
[2]
Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase [J].
Amin, A ;
Zaccardi, J ;
Mullen, S ;
Olland, S ;
Orlowski, M ;
Feld, B ;
Labonte, P ;
Mak, P .
VIROLOGY, 2003, 313 (01) :158-169
[3]
[Anonymous], FIELDS VIROLOGY
[4]
DIK, a novel protein kinase that interacts with protein kinase Cδ -: Cloning, characterization, and gene analysis [J].
Bähr, C ;
Rohwer, A ;
Stempka, L ;
Rincke, G ;
Marks, F ;
Gschwendt, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (46) :36350-36357
[5]
Sequence and structure-based prediction of eukaryotic protein phosphorylation sites [J].
Blom, N ;
Gammeltoft, S ;
Brunak, S .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (05) :1351-1362
[6]
Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus [J].
Bressanelli, S ;
Tomei, L ;
Roussel, A ;
Incitti, I ;
Vitale, RL ;
Mathieu, M ;
De Francesco, R ;
Rey, FA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) :13034-13039
[7]
Structural analysis of the hepatitis C virus RNA polymerase in complex with Ribonucleotides [J].
Bressanelli, S ;
Tomei, L ;
Rey, FA ;
De Francesco, R .
JOURNAL OF VIROLOGY, 2002, 76 (07) :3482-3492
[8]
A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[9]
Phosphorylation of serine 1106 in the catalytic domain of topoisomerase IIα regulates enzymatic activity and drug sensitivity [J].
Chikamori, K ;
Grabowski, DR ;
Kinter, M ;
Willard, BB ;
Yadav, S ;
Aebersold, RH ;
Bukowski, RM ;
Hickson, ID ;
Andersen, AH ;
Ganapathi, R ;
Ganapathi, MK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (15) :12696-12702
[10]
ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362